Serina Therapeutics, Inc. (SER) stock
SERNYSEPharmaceutical PreparationsFiscal year ends December 31
$1.42+0.03 (+2.16%)
Close on Nov 16, 2026Market cap $36.07MP/E –Yield –
Serina Therapeutics pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
Serina Therapeutics's pe ratio was 12.2× on Apr 30, 2024.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2024 | Apr 30, 2024 | 12.2× | +2.5 |
| 2023 | Dec 29, 2023 | 9.6× | – |
See a number that looks wrong?